Mayne Pharma (MYX:LSE) Investor Relations Material

Overview

Mayne Pharma is an Australian specialty pharmaceutical company that is listed on the ASX. The company focuses on bringing both novel and generic pharmaceuticals to market and also offers development and manufacturing services to clients around the world. Mayne Pharma is best known for its oral drug delivery systems and distribution of specialty pharmaceutical products in areas such as dermatology, women’s health, and infectious diseases. The company is committed to advancing healthcare through innovation and improving patient outcomes.

Frequently Asked Questions

What is Mayne Pharma's ticker?

Mayne Pharma's ticker is MYX

What exchange is Mayne Pharma traded on?

The company's shares trade on the LSE stock exchange

Where are Mayne Pharma's headquarters?

They are based in Duluth, Minnesota

How many employees does Mayne Pharma have?

There are 51-200 employees working at Mayne Pharma

What is Mayne Pharma's website?

It is https://www.maynepharma.com/

What type of sector is Mayne Pharma?

Mayne Pharma is in the Industrial Goods sector

What type of industry is Mayne Pharma?

Mayne Pharma is in the Pollution & Treatment Controls industry

Who are Mayne Pharma's peers and competitors?

The following five companies are Mayne Pharma's industry peers:

- AEGON N.V.

- Donaldson Company

- Advanced Emissions Solutions

- BioHiTech Global, Inc.

- Evoqua Water